Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders-Reference-Cited by-同舟云学术

Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders

Published:2015-07-14 Issue:11 Volume:31 Page:885-890
ISSN:0951-3590
Container-title:Gynecological Endocrinology
language:en
Short-container-title:Gynecological Endocrinology

Author:

Polyzos Nikolaos P.,Corona Roberta,Van De Vijver Arne,Blockeel Christophe,Drakopoulos Panagiotis,Vloeberghs Veerle,De Vos Michel,Camus Michel,Humaidan Peter,Tournaye Herman

Publisher

Informa UK Limited

Subject

Obstetrics and Gynaecology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.tandfonline.com/doi/pdf/10.3109/09513590.2015.1065481

Reference22 articles.

1. Young age does not protect against the adverse effects of reduced ovarian reserve—an eight year study

2. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?

3. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria

4. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria

5. Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem-Cell-Derived Extracellular Vesicles: Unlocking New Possibilities for Treating Diminished Ovarian Reserve and Premature Ovarian Insufficiency;Life;2023-11-23

2. Low responders may benefit from undergoing ovarian stimulation with a long GnRH agonist protocol with corifollitropin alfa followed by hMG;JBRA Assisted Reproduction;2023

3. Does the dose or type of gonadotropins affect the reproductive outcomes of poor responders undergoing modified natural cycle IVF (MNC-IVF)?;European Journal of Obstetrics & Gynecology and Reproductive Biology;2022-11

4. Poor ovarian response and the possible role of natural and modified natural cycles;Therapeutic Advances in Reproductive Health;2022-01

5. Expectant Management Before In vitro Fertilization in Women Aged 39 or Above and Unexplained Infertility Does Not Decrease Live Birth Rates Compared to Immediate Treatment;Reproductive Sciences;2021-11-01